The latest price target for CME Group (NASDAQ:CME) was reported by Argus Research on March 4, 2026. The analyst firm set a price target for $0.00 expecting CME to fall to within 12 months (a possible -100.00% downside). 39 analyst firms have reported ratings in the last year.

The latest analyst rating for CME Group (NASDAQ:CME) was provided by Argus Research, and CME Group downgraded their hold rating.

The last upgrade for CME Group Inc happened on January 14, 2026 when TD Cowen raised their price target to $305. TD Cowen previously had a hold for CME Group Inc.

The last downgrade for CME Group Inc happened on March 4, 2026 when Argus Research changed their price target from N/A to N/A for CME Group Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CME Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CME Group was filed on March 4, 2026 so you should expect the next rating to be made available sometime around March 4, 2027.

While ratings are subjective and will change, the latest CME Group (CME) rating was a downgraded with a price target of $0.00 to $0.00. The current price CME Group (CME) is trading at is $298.31, which is out of the analyst’s predicted range.